Nareth Kong

Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia

J. Juliano, D. Saunders, J. Patel, 2017, Malaria Journal.

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.

S. Meshnick, J. Juliano, D. Saunders, 2015, The Lancet. Infectious diseases.

Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance

S. Tyner, Christopher G. Jacob, D. Saunders, 2015, Antimicrobial Agents and Chemotherapy.

Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand

Philip Smith, D. Saunders, Chanthap Lon, 2016, Malaria Journal.

Atovaquone-Proguanil in Combination With Artesunate to Treat Multidrug-Resistant P. falciparum Malaria in Cambodia: An Open-Label Randomized Trial.

D. Saunders, M. Fukuda, Philip L. Smith, 2019, Open forum infectious diseases.

Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia

M. Fukuda, Philip L. Smith, R. Huy, 2020, PloS one.

Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine

D. Saunders, Michele D Spring, C. Lanteri, 2014, Malaria Journal.

Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand

D. Saunders, M. Fukuda, Philip L. Smith, 2016, Malaria Journal.